Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Sinopharm COVID-19 Booster Vaccine
NCT05172193Phase 2Unknown
- Sponsor
- Kimia Farma
- Start
- Dec 2021
- Primary completion
- Sep 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Kimia Farma. Status: unknown.
02
Drugs
BBIBP-CorV
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05172193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05172193.